London, UK, 31 August 2018: LifeArc®, one of the UK’s leading medical research charities, proudly announces that its Centre for Diagnostic Development (CDD) has just been accredited by the British Standards Institution (BSI) less than a year since opening in a new location in Edinburgh, Scotland. The CDD is the only LifeArc facility that is focused solely on designing and developing commercially viable molecular diagnostic tests and this new certificate is validation of the high quality of LifeArc’s products.
Dr Michael Dalrymple, Executive Director of Diagnostics and Science Foresight, LifeArc comments: “Our dedicated team here at the CDD is delighted that the quality of our work has been recognised by the BSI and we hope this is very reassuring for our current and future partnerships. We have always provided an efficient and tailored diagnostic service for our partners and we hope that this certificate provides appropriate quality assurance that is needed to attract additional research projects from the thriving medical research community we are lucky enough to be a part of here in Edinburgh and beyond.”
The centre’s main aim is to pioneer the design and development of molecular in vitro devices (IVDs), thereby turning great science into even greater patient impact.
LifeArc continuing focus will be the design and development of molecular diagnostic tests focusing on oncology, infectious disease and precision medicine. Potential partners will benefit from LifeArc’s expertise and industry experience and introductions to potential industry partners. If you would like to know more about LifeArc’s diagnostic development capability please click here.
Communications at LifeArc